Due to the pivotal role of IgG1 in response against SARS-CoV-2, we hypothesized that common functional variants in the IGHG1 gene—either individually or synergistically with IGHG3 and FCGR2A—might modulate the extent of COVID-19 severity. The gene discussed is FCGR2A; the disease is COVID-19.